Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More
This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More
This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More
Submitted by
admin
on October 4, 2021 - 10:37am
Source:
Motley Fool, clinical trials,
News Tags:
IPOs
drug delivery
Rani Therapeutics
Headline:
This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More
snippet:
Early clinical trials exhibit an encouraging success rate for the pill.
A July 30 IPO brought enough cash to fund operations through the end of 2023.
Second-quarter earnings results beat estimates by 33%.
Do Not Allow Advertisers to Use My Personal information
